Waldenstrom's Macroglobulinemia Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
Conditions: Follicular Lymphoma; Mantle Cell Lymphoma; Hairy Cell Leukemia; Lymphoplasmacytic Lymphoma; Burkitt Lymphoma; Marginal Zone Lymphoma; Waldenstrom Macroglobulinemia Interventions: Drug: CD22CART Infusion Sponsors: Stanford University; The Leukemia and Lymphoma Society Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Preliminary Assessment of [18F]BL40 in PET/CT Scans
Conditions: Diffuse Large B-cell Lymphoma; Multiple Myeloma; Mantle Cell Lymphoma; Marginal Zone Lymphoma; Chronic Lymphocytic Leukemia; Waldenstr öm Macroglobulinemia Interventions: Diagnostic Test: 18F-BL40 PET/CT; Diagnostic Test: 18F-FDG PET/CT; Diagnostic Test: Routine Blood Draw - Phase 1 only Sponsors: British Columbia Cancer Agency Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Patients Treated in Real Life With VEnetoclax for WAldenstr öm Macroglobulinemia
Conditions: Waldenstrom ' s Macroglobulinaemia Refractory Interventions: Drug: Venetoclax Sponsors: Poitiers University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
Conditions: Chronic Lymphocytic Leukemia; Hematopoietic and Lymphoid System Neoplasm; Mantle Cell Lymphoma; Marginal Zone Lymphoma; Waldenstrom Macroglobulinemia Interventions: Other: Non-Interventional Study Sponsors: Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials
OCT and OCTA Deep Learning in Waldenstr öm's Macroglobulinemia Patients
Conditions: Waldenstrom Macroglobulinemia Sponsors: Federico II University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials
A Phase 2 Clinical Trial to Evaluate Zanubrutinib Combined With BR (Bendamustine/Rituximab) Regimen in Subjects With Newly-diagnosed Waldenstr öm's Macroglobulinemia
Condition: Waldenström's Macroglobulinemia Intervention: Drug: zanubrutinib,bendamustine,rituximab Sponsors: Shanghai Changzheng Hospital; RenJi Hospital; Huashan Hospital; Shanghai 6th People's Hospital; Huadong Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2023 Category: Research Source Type: clinical trials
Study to Evaluate the Efficacy and Safety of BGB-11417 in Participants With Waldenstr öm's Macroglobulinemia
Conditions: Waldenstrom Macroglobulinemia; Waldenstrom's Macroglobulinemia Recurrent; Waldenstrom's Macroglobulinemia Refractory Intervention: Drug: BGB-11417 Sponsor: BeiGene Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 19, 2023 Category: Research Source Type: clinical trials
